1 month on tirzepatide Compounded first month tirzepatide weight loss

These hormones play crucial roles in regulating appetite, slowing gastric emptying, and managing blood sugar levels

A higher dose of Wegovy (7.2 mg) was approved by the MHRA in January 2026 following the STEP UP trial, which showed: 2 Wegovy 7.2 mg: 20.7% average weight loss Wegovy 2.4 mg: 17.5% average weight loss 50.9% of those on 7.2 mg lost at least 20% of body weight The 7.2 mg dose is not a starting dose

Gentle rotation NOT vortexing Do not vortex the reconstituted peptide directly

Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of information you have read from the Toronto Functional Medicine Centre website or other affiliate media

Stagger your orders so each vial arrives as you need it, with fresh BUD dates